Skip to content

Comparison of Diagnostic Performance of Cerebrospinal Fluid ?-FLC in MS: A Multicenter Study from Six Cities in Northern China

Comparison of Diagnostic Performance of Cerebrospinal Fluid ?-FLC in MS: A Multicenter Study from Six Cities in Northern China

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110209
Enrollment
Unknown
Registered
2025-10-10
Start date
2025-01-07
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Interventions

Observational group:Patients with suspected MS, CIS, or RIS

Sponsors

Yan'an University Xianyang Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with suspected central nervous system disease were enrolled and later classified following the diagnostic procedure upon confirmation; 2. Aged 18 - 80, regardless of gender; 3. Agreed to undergo a lumbar puncture, with known status of cerebrospinal fluid and serum ? - free light chains (? - FLC), albumin, and oligoclonal bands (OCB); 4. Provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with peripheral nervous system disorders, infectious or neoplastic central nervous system diseases (monoclonal gammopathy or severe chronic kidney injury (GFR glomerular filtration rate <30 mL/min/1.73 m^2). 2. Patients with severe mental illnesses that prevent cooperation with tests or follow - up, and those who cannot or refuse to sign the informed consent form (or their legal representatives), are excluded from this study.

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of CSF ?-FLC-related indices and OCB;

Secondary

MeasureTime frame
Diagnostic performance of cerebrospinal fluid ?-FLC-related indices and OCB;

Countries

China

Contacts

Public ContactZhang Guoxun

Yan'an University Xianyang Hospital

guoxun.zhang@hotmail.com+86 18629430340

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026